Aligning economic incentives with global health goals is not only a moral imperative but a practical necessity for economic ...

The experimental monoclonal antibody drug acts like a shield to protect insulin-producing cells from damage, even extending ...

In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the ...

Allied Market Research published a report, titled, “Antibody Production Market by Product (Instruments, Consumables), Process (Upstream Processing, Downstream Processing), and End User (Pharmaceutical ...

A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and ...

Johns Hopkins researchers have shown that a monoclonal antibody can reverse type 1 diabetes. It targets a different antigen ...

CVS is getting into the business of making copycat biologic drugs, known as biosimilars, to profit directly from blockbusters ...

A $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its ...

Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a ...

Discover how Santen Pharmaceutical's monoclonal antibody targeting VEGF offers groundbreaking advancements in treating eye diseases and cancers.

StarBright Dyes are compatible with most experimental protocols and flow cytometers, including the Bio-Rad ZE5 Cell Analyzer, ...

Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food and Drug Administration (FDA) approval and rapidly growing market size as discussed in previous ...